DA Davidson raised the firm’s price target on Nordson (NDSN) to $290 from $285 and keeps a Buy rating on the shares after its Q4 earnings beat. The firm is positive on the company’s operating margin uplift, largely within the MFS – Medical and Fluid Solutions – segment driven by divestiture benefits and volume recovery, while its inbound order entry within Advanced Technology Solutions appears healthy, the analyst tells investors in a research note. Nordson’s balance sheet also remains sound, giving ample opportunity for additional buybacks, the firm added.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDSN:
